Knowledge, attitude and practice of healthcare professionals towards infliximab and insulin glargine biosimilars: result of a UK web-based survey.

ABSTRACT:

Objective

To investigate healthcare professionals' knowledge and attitudes towards infliximab and insulin glargine biosimilars and the factors influencing their prescribing. Then, to compare healthcare professionals' attitudes with the utilisation of these biosimilars in UK hospitals.

Design

Self-administered, one-time web-based survey and drug utilisation analysis.

Setting and data sources

Professional associations and societies in the field of dermatology, diabetology, gastroenterology and rheumatology in the UK, between 8 August 2016 and 8 January 2017. The volume of utilisation of branded and biosimilar infliximab and insulin glargine in UK hospitals was derived from the DEFINE database, between 2015 and 2016.

Outcomes

Participants' knowledge and awareness

SUBMITTER: Chapman SR 

PROVIDER: S-EPMC5726079 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature